Clinical Trials Logo

Clinical Trial Summary

This study aim to clarify the participants's mental state with Demoralization Scale- Mandarin Version(DS-MV). Based on clinical observations and literature review, investigators assume participants's DS-MV score high correlation with PHQ-9 score.


Clinical Trial Description

The Chinese version of Demoralization Scale-Mandarin Version (DS-MV) was used to assess the mental state of patients with stroke after debridement. The statistical analysis test of correlation is carried out, and the reliability and validity test and the norm establishment of the Chinese version are further tested. Convenient sampling will be performed at a single medical facility. The planned implementation period is 2019/01/01 ~ 2019/12/31, and the location of the case is the rehabilitation ward and outpatient clinic of Taoyuan Hospital. The diagnosis must be: intensive stroke or hemorrhagic brain within three years. In the case of a 20- to 100-year-old clinical patient with stroke, the subject should explain the content of the case, and the subject will complete the test consent form after informed consent, and then begin the evaluation process of the self-assessment questionnaire. The assessment procedure is preceded by a clinical psychologist conducting with MMSE test to determine the cognitive function. When the patient's consciousness is blurred, the simple intelligent state test (MMSE) score less than 24 points, aphasia can not be effectively communicated, the diagnosis of mental illness or mental disorder has been recorded on the medical record, or the patient or family member is unwilling to sign the informed consent form. If the above situation is met, subjects will be excluded. The self-assessment questionnaire will obtain the scores of the subjects in the Chinese version of the Demoralization Scale-Mandarin Version (DS-MV) and the Patient Health Questionnaire (PHQ-9). Statistical analysis, as well as the Chinese version of the loss of the scale of the reliability and validity of the test and the establishment of clinical norm scores. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03829397
Study type Observational
Source Taoyuan General Hospital
Contact
Status Completed
Phase
Start date February 18, 2019
Completion date March 24, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05612659 - Developing an EEG Probe for Studying and Modulating Cognitive Control N/A
Completed NCT04093843 - TMS for Post Stroke Depression N/A
Recruiting NCT05516680 - Effects and Central Mechanism of Electroacupuncture and MRI-navigated rTMS for PSD N/A
Recruiting NCT04876066 - Use of Transmucosal Ketamine in Post Stroke Depression Phase 1
Recruiting NCT03159351 - The Antidepressant Effects of rTMS After Ischemic Stroke N/A
Recruiting NCT03864484 - iPad Application-based Intervention for Post-stroke Depression N/A
Recruiting NCT05310175 - Efficacy of Acupuncture at Acupoints Group Around the Base of Skull for Post-Stroke Depression N/A
Completed NCT03639259 - Emotional and Cognitive Determinants of Post-stroke Fatigue
Completed NCT02472613 - Acupuncture for Ischemic Post-stroke Depression N/A
Completed NCT04008719 - ATtention Test and Executive Functions After STroke to Predict Depression. N/A
Recruiting NCT05241782 - The Effect of Auricular Acupressure on the Improvement of Anxiousness, Depression and Heart Rate Variability in Stroke Patients N/A
Withdrawn NCT03761303 - rTMS as an add-on Therapy in Patients With Post-stroke Depression N/A
Completed NCT04318951 - Impact of Intensive Social Interaction on Post-Stroke Depression in Individuals With Aphasia N/A
Completed NCT04560413 - Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients
Recruiting NCT05187975 - Integrated Rehabilitation in Treating Post-stroke Depression N/A
Completed NCT06157333 - Efficacy of Accelerated Repetitive Transcranial Magnetic Stimulation on Patients With Post-stroke Depression N/A
Recruiting NCT03256305 - A Study of rTMS Personalized Precision Treatment of Post-stroke Depression N/A
Recruiting NCT03789994 - Affective Touching on Poststroke Depression N/A
Completed NCT05932550 - Safety of Maraviroc for Post-stroke Depression Phase 2
Recruiting NCT03903068 - Transcranial Alternating Current Stimulation Treating Post-stroke Depression N/A